MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $153,000 | +23.4% | 124,036 | +207.0% | 0.01% | +40.0% |
| Q1 2017 | $124,000 | -50.4% | 40,402 | -34.1% | 0.01% | -66.7% |
| Q4 2016 | $250,000 | -46.8% | 61,304 | -17.3% | 0.02% | -53.1% |
| Q3 2016 | $470,000 | +1205.6% | 74,116 | +984.2% | 0.03% | +1500.0% |
| Q2 2016 | $36,000 | -42.9% | 6,836 | -10.6% | 0.00% | -60.0% |
| Q1 2016 | $63,000 | -37.6% | 7,644 | -40.4% | 0.01% | -37.5% |
| Q4 2015 | $101,000 | +29.5% | 12,824 | +102.1% | 0.01% | +14.3% |
| Q2 2015 | $78,000 | – | 6,346 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 514,853 | $2,595,000 | 2.23% |
| GARRISON BRADFORD & ASSOCIATES INC | 98,001 | $494,000 | 0.48% |
| Catalyst Capital Advisors LLC | 380,896 | $1,920,000 | 0.44% |
| Knoll Capital Management, LLC | 160,585 | $809,000 | 0.42% |
| Tekla Capital Management LLC | 757,050 | $3,816,000 | 0.38% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 524,800 | $2,645,000 | 0.13% |
| Integre Asset Management, LLC | 103,493 | $522,000 | 0.12% |
| CAMBRIDGE TRUST CO | 220,003 | $1,109,000 | 0.10% |
| JAMISON EATON & WOOD INC /NJ | 62,782 | $316,000 | 0.09% |
| STONERIDGE INVESTMENT PARTNERS LLC | 88,304 | $445,000 | 0.09% |